Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion type Assertion NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_head.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion wasGeneratedBy ECO_0000203 NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_provenance.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion wasDerivedFrom gad-20150221 NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_provenance.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion SIO_000772 15248218 NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_provenance.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion evidence source_evidence_literature NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_provenance.
- NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_assertion description "[Patients who were either heterozygous or homozygous for CYP2C19*2 had a significantly lower risk of developing premature ovarian failure (relative risk 0.10; 95% confidence interval 0.02-0.52), after adjustment for age and total number of cyclophosphamide pulses received.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55033.RAaSVeiUo7_7LD79JsOM_YsgIku1rLdpjCuEE5F9bB2x4130_provenance.